Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sunday, December 21, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
People on the Move
Ankyra Appoints Sailaja Battula, PhD, as Chief Scientific Officer
Life Sciences Times
-
December 15, 2025
0
Featured
Capital Discipline Matters: Sam Zell’s Lessons for Every Entrepreneur
Life Sciences Times
-
December 13, 2025
0
Pharma
Acadia Pharmaceuticals Wins FDA Approval for DAYBUE STIX Powder Formulation for Rett Syndrome
Life Sciences Times
-
December 12, 2025
0
Pharma
ImmunityBio Wins EMA Recommendation for Conditional Approval of ANKTIVA With BCG for Bladder Cancer
Life Sciences Times
-
December 12, 2025
0
Venture Capital
Cosette Pharmaceuticals Terminates Agreement to Acquire Mayne Pharma
Life Sciences Times
-
December 12, 2025
0
Pharma
Innoviva Specialty Therapeutics Reports Lancet Publication of Positive Phase 3 Data for Zoliflodacin in Gonorrhea
Life Sciences Times
-
December 12, 2025
0
Biotech
NeuraLight Adds Nobel Laureate Thomas Südhof to Scientific Advisory Board, Names Olivier Rascol as Chair
Life Sciences Times
-
December 12, 2025
0
Venture Capital
Kymera Therapeutics Closes Upsized $602 Million Public Offering, Underwriters Fully Exercise Option
Life Sciences Times
-
December 12, 2025
0
Technology
Sunoh.ai joins athenahealth Marketplace to expand access to AI-driven clinical documentation
Life Sciences Times
-
December 11, 2025
0
Biotech
Phare Bio and Basilea form partnership to develop AI-designed broad-spectrum antibiotic
Life Sciences Times
-
December 11, 2025
0
1
...
3
4
5
...
773
Page 4 of 773
Most Popular
Manifold Raises $18 Million Series B to Expand Vertical AI Platform for Life Sciences
December 19, 2025
PureTech Appoints Robert Lyne as Chief Executive Officer
December 19, 2025
Orum Therapeutics Raises Approximately $100 Million to Advance Degrader Antibody Conjugate Programs
December 19, 2025
Syremis Therapeutics Launches With $165 Million Series A to Advance New Treatments for Mental Health Disorders
December 19, 2025
Load more
Recent Comments
Recent Comments